Amphista Therapeutics raised €6.7M in a Series A round in Jul 2020. The company is based in Motherwell, UK. Investors in the round: Advent Life Sciences. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
